Advertisement

Knee Surgery, Sports Traumatology, Arthroscopy

, Volume 27, Issue 10, pp 3304–3310 | Cite as

Arthroscopic irrigation and debridement is associated with favourable short-term outcomes vs. open management: an ACS-NSQIP database analysis

  • Mhamad Faour
  • Assem A. Sultan
  • Jaiben George
  • Linsen T. Samuel
  • Gannon L. Curtis
  • Robert Molloy
  • Carlos A. Higuera
  • Michael A. MontEmail author
KNEE

Abstract

Purpose

Septic arthritis of the knee is an orthopaedic emergency that is associated with marked morbidity and can potentially be life threatening. Surgical debridement can be performed either arthroscopically or via an arthrotomy. The aim of this study was to compare the 30-day complications and adverse outcomes between the two procedures.

Methods

Patients with a diagnosis of septic arthritis of the knee between 2011 and 2015 were identified using the ACS-NSQIP database. The study population included 695 patients, who had knee septic arthritis and underwent either an arthroscopic irrigation or debridement (I&D) (n = 464) or open irrigation and debridement (n = 231). Preoperative data included demographics, independent functional status, and comorbidities. Outcomes of interest included wound complications, infectious complications, cardiovascular events, hospital readmissions, and reoperations, or any of the previous adverse events.

Results

Both cohorts were similar in most baseline characteristics. Bleeding requiring transfusion was significantly lower in the arthroscopic (n = 13; 3.6%) compared to the open procedure (n = 31; 13.4%; p = 0.0001). Home discharge was significantly higher in the arthroscopic irrigation and debridement group (n = 310; 67.5%) compared to the open group (n = 126; 55%; p = 0.0013). The overall incidence of adverse events was lower in the arthroscopic group (n = 158; 34%) compared to the open group (n = 112; 49%; p = 0.0002). There was no difference in rates of infectious complications, thromboembolic events, hospital readmission, reoperation, or mortality between the groups. Open irrigation and debridement was associated with higher risk of bleeding requiring transfusion (OR = 3.79; 95% CI: 2.02–7.13; p = 0.0001), higher risk of incidence of adverse events (OR = 1.46; 95% CI: 1.02–2.08; p = 0.039), and lower home discharge (OR = 3.79; 95% CI: 2.02–7.13; p = 0.0001) within 30 days after the procedure.

Conclusion

Arthroscopic irrigation and debridement demonstrated favourable short-term outcomes. Patients who underwent arthroscopic irrigation and debridement had lower rates of blood transfusions, lower rates of adverse events, and higher home discharge rates compared to open irrigation and debridement. This study is the largest analysis comparing arthroscopic vs. open irrigation and debridement in a national database sample. These findings conclude that arthroscopic debridement can be an alternative first-line option in managing septic arthritis.

Level of evidence

III.

Keywords

Septic arthritis Knee Irrigation and debridement Arthroscopy Arthrotomy Outcomes Complications Infection Arthroscopic Open I&D 

Abbreviations

ACS-NSQIP

American College of Surgeons National Surgical Quality Improvement Program

I&D

Incision and drainage

OR

Odds ratio

CI

Confidence interval

SD

Standard deviation

BMI

Body mass index

ICD-9

International Classification of Disease, 9th edition

CPT

Current Procedural Technology code

UTI

Urinary tract infection

n.s.

Non-significant

DVT

Deep vein thrombosis

PE

Pulmonary embolism

ASA

American Society of Anesthesiologists

Notes

Acknowledgements

American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating in the ACS-NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.

Author contributions

MF conceived of the study and drafted the manuscript; JG participated in the design of the study and performed the statistical analysis; AS participated in its design and coordination and helped to draft the manuscript. LTS participated in its design and coordination and helped to draft the manuscript; GLS participated in its design and coordination and helped to draft the manuscript; RM participated in its design and coordination; CAH participated in its design and coordination; and MAM participated in its design and coordination. All authors read and approved the final manuscript.

Funding

There is no funding source.

Compliance with ethical standards

Conflict of interest

Mhamad Faour, MD, declares that he has no competing interests. Assem Sultan, MD, declares that he has no competing interests. Jaiben George, MD, declares that he has no competing interests. Linsen T. Samuel, MD, MBA, declares that he has no competing interests. Gannon L. Curtis, MD, declares that he has no competing interests. Robert Molloy, MD: Stryker: paid consultant; Paid presenter or speaker; research support. Zimmer: research support. Carlos A. Higuera, MD: 3M: research support. American Association of Hip and Knee Surgeons: Board or committee member. American Journal of Orthopedics: editorial or governing board. CD Diagnostics: research support. Cempra: research support. Cymedica: research support. Ferring pharmaceuticals: research support. Journal of Hip Surgery: editorial or governing board. Journal of Knee Surgery: Editorial or governing board. KCI: paid consultant; paid presenter or speaker; research support. Mid-American Orthopaedic Association: board or committee member. Musculoskeletal Infection Society: board or committee member. OREF: research support. Orthofix, Inc.: research support. Pfizer: paid consultant. PSI: stock or stock options. Stryker: research support. TenNor Therapeutics Limited: paid consultant. Zimmer: paid consultant; research support. Michael A. Mont, MD. AAOS: board or committee member. Abbott: paid consultant. Cymedica: paid consultant. DJ Orthopaedics: paid consultant; research support. Johnson & Johnson: paid consultant; research support. Journal of Arthroplasty: editorial or governing board. Journal of Knee Surgery: editorial or governing board. Mallinckrodt Pharmaceuticals: paid consultant. Microport: IP royalties. National Institutes of Health (NIAMS & NICHD): research support. Ongoing Care Solutions: paid consultant; research support. Orthopedics: editorial or governing board. Orthosensor: paid consultant; research support. Pacira: paid consultant. Peerwell: stock or stock options. Performance Dynamics Inc.: paid consultant. Sage: paid consultant. Stryker: IP royalties; paid consultant; research support. Surgical Techniques International: editorial or governing board. TissueGene: paid consultant; research support.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Atkins B, Bowler ICJW (1998) The diagnosis of large joint sepsis. J Hosp Infect 40:263–274CrossRefGoogle Scholar
  2. 2.
    Sonnery-Cottet B, Archbold P, Zayni R, Bortolletto J, Thaunat M, Prost T, Padua VBC, Chambat P (2011) Prevalence of septic arthritis after anterior cruciate ligament reconstruction among professional athletes. Am J Sports Med 39:2371–2376CrossRefGoogle Scholar
  3. 3.
    Balabaud L, Gaudias J, Boeri C, Jenny J-Y, Kehr P (2007) Results of treatment of septic knee arthritis: a retrospective series of 40 cases. Knee Surg Sports Traumatol Arthrosc 15:387–392CrossRefGoogle Scholar
  4. 4.
    Van Tongel A, Stuyck J, Bellemans J, Vandenneucker H (2007) Septic arthritis after arthroscopic anterior cruciate ligament reconstruction: a retrospective analysis of incidence, management and outcome. Am J Sports Med 35:1059–1063CrossRefGoogle Scholar
  5. 5.
    Wang C, Lee YHD, Siebold R (2014) Recommendations for the management of septic arthritis after ACL reconstruction. Knee Surg Sports Traumatol Arthrosc 22:2136–2144CrossRefGoogle Scholar
  6. 6.
    Dave OH, Patel KA, Andersen CR, Carmichael KD (2016) Surgical procedures needed to eradicate infection in knee septic arthritis. Orthopedics 39:50–54CrossRefGoogle Scholar
  7. 7.
    Kuo C-L, Chang J-H, Wu C-C, Shen P-H, Wang C-C, Lin L-C, Shen H-C, Lee C-H (2011) Treatment of septic knee arthritis: comparison of arthroscopic debridement alone or combined with continuous closed irrigation-suction system. J Trauma Inj Infect Crit Care 71:454–459CrossRefGoogle Scholar
  8. 8.
    Mathews CJ, Kingsley G, Field M, Jones A, Weston VC, Phillips M, Walker D, Coakley G (2007) Management of septic arthritis: a systematic review. Ann Rheum Dis 66:440–445Google Scholar
  9. 9.
    Stutz G, Kuster MS, Kleinstück F, Gächter A (2000) Arthroscopic management of septic arthritis: stages of infection and results. Knee Surg Sports Traumatol Arthrosc 8:270–274CrossRefGoogle Scholar
  10. 10.
    Ivey M, Clark R (1985) Arthroscopic debridement of the knee for septic arthritis. Clin Orthop Relat Res 199:201–206Google Scholar
  11. 11.
    Johns BP, Loewenthal MR, Dewar DC (2017) Open compared with arthroscopic treatment of acute septic arthritis of the native knee. J Bone Jt Surg 99:499–505CrossRefGoogle Scholar
  12. 12.
    Sammer DM, Shin AY (2009) Comparison of arthroscopic and open treatment of septic arthritis of the wrist. J Bone Jt Surg 91:1387–1393CrossRefGoogle Scholar
  13. 13.
    Schröder JH, Krüger D, Perka C, Hufeland M (2016) Arthroscopic treatment for primary septic arthritis of the hip in adults. Adv Orthop 2016:8713037CrossRefGoogle Scholar
  14. 14.
    NSQIP. American College of Surgeons National Surgical Quality Improvement Program. n.d. https://www.facs.org/quality-programs/acs-nsqip?. Accessed 1 June 2018
  15. 15.
    Khuri SF (2005) The NSQIP: a new frontier in surgery. Surgery 138:837–843CrossRefGoogle Scholar
  16. 16.
    Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T (2013) Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol 20:3212–3217CrossRefGoogle Scholar
  17. 17.
    Pugely AJ, Callaghan JJ, Martin CT, Cram P, Gao Y (2013) Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP. J Arthroplasty 28:1499–1504CrossRefGoogle Scholar
  18. 18.
    Shirtliff ME, Mader JT (2002) Acute septic arthritis. Clin Microbiol Rev 15:527–544CrossRefGoogle Scholar
  19. 19.
    Bovonratwet P, Nelson SJ, Bellamkonda K, Ondeck NT, Shultz BN, Medvecky MJ, Grauer JN (2018) Similar 30-day complications for septic knee arthritis treated with arthrotomy or arthroscopy: an american college of surgeons national surgical quality improvement program analysis. Arthroscopy 34:213–219CrossRefGoogle Scholar
  20. 20.
    Dubost JJ, Fis I, Denis P, Lopitaux R, Soubrier M, Ristori JM, Bussiere JL, Sirot J, Sauvezie B (1993) Polyarticular septic arthritis. Medicine (Baltimore) 72:296–310CrossRefGoogle Scholar
  21. 21.
    Böhler C, Pock A, Waldstein W, Staats K, Puchner SE, Holinka J, Windhager R (2017) Surgical treatment of shoulder infections: a comparison between arthroscopy and arthrotomy. J Shoulder Elbow Surg 26:1915–1921CrossRefGoogle Scholar
  22. 22.
    Aïm F, Delambre J, Bauer T, Hardy P (2015) Efficacy of arthroscopic treatment for resolving infection in septic arthritis of native joints. Orthop Traumatol Surg Res 101:61–64CrossRefGoogle Scholar

Copyright information

© European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA) 2019

Authors and Affiliations

  • Mhamad Faour
    • 1
  • Assem A. Sultan
    • 1
  • Jaiben George
    • 1
  • Linsen T. Samuel
    • 1
  • Gannon L. Curtis
    • 1
  • Robert Molloy
    • 1
  • Carlos A. Higuera
    • 2
  • Michael A. Mont
    • 3
    Email author
  1. 1.Department of Orthopaedic SurgeryCleveland Clinic FoundationClevelandUSA
  2. 2.Department of Orthopaedic SurgeryCleveland Clinic FloridaWestonUSA
  3. 3.Department of Orthopaedic SurgeryLenox Hill HospitalNew YorkUSA

Personalised recommendations